Clinical Trials
All Clinical Trials - Page 52 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00116220Phase 3Completed
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
Gonadorelin
- NCT00002633Phase 3Completed
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00004426N/ACompleted
Leuprolide in Determining the Cause of Gonadotropin Deficiency
Gonadorelin
- NCT00001322Phase 1/Phase 2Completed
The Effects of Reproductive Hormones on Mood and Behavior
Gonadorelin
- NCT00004332N/ACompleted
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
Sermorelin
- NCT00004763Phase 2Completed
Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Gonadorelin
- NCT00004771Phase 2Completed
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
Gonadorelin
- NCT00660010Phase 3Completed
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Gonadorelin
- NCT00004311Phase 2Completed
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Gonadorelin
- NCT00383656Phase 2Unknown
Pulsatile GnRH in Anovulatory Infertility
Gonadorelin
- NCT00849082Phase 3Completed
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00004330N/ACompleted
Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Gonadorelin
- NCT00001190Phase 2Completed
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
Gonadorelin
- NCT07629401N/AAvailable
Provide Pre-approval Expanded Access of LY3437943
Retatrutide
- NCT00001036Phase 1Completed
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
Thymosin-Alpha-1
- NCT00082082Phase 2Completed
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Thymosin-Alpha-1
- NCT04689360N/AAvailable
An Intermediate Size Expanded Access Protocol of Elamipretide
Elamipretide
- NCT00438217Phase 4Unknown
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Gonadorelin
- NCT01240928Phase 1Withdrawn
MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer
Gonadorelin
- NCT02065323Phase 2Withdrawn
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Gonadorelin
- NCT00669786Phase 3Completed
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT00003517Phase 2Withdrawn
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Gonadorelin